Search Results - Kato M
- Showing 1 - 6 results of 6
-
1
TGF-β-Induced TMEPAI Attenuates the Response of Triple-Negative Breast Cancer Cells to Doxorubicin and Paclitaxel by Wardhani BWK, Puteri MU, Watanabe Y, Louisa M, Setiabudy R, Kato M
Published 2020Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
2
Effect of denosumab on bone mineral density in Japanese women with osteopenia treated with aromatase inhibitors for breast cancer: subgroup analyses of a Phase II study by Nakatsukasa K, Koyama H, Ouchi Y, Sakaguchi K, Fujita Y, Matsuda T, Kato M, Konishi E, Taguchi T
Published 2018Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
3
Clinical Significance of Continuable Treatment with Nintedanib Over 12 Months for Idiopathic Pulmonary Fibrosis in a Real-World Setting by Kato M, Sasaki S, Tateyama M, Arai Y, Motomura H, Sumiyoshi I, Ochi Y, Watanabe J, Ihara H, Togo S, Takahashi K
Published 2021Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
4
Venous anastomosis procedure for treatment of lymphatic malformation in Klippel-Trenaunay syndrome by Motoi Kato, M.D, Shoji Watanabe, M.D. PhD, Takuya Iida, M.D. PhD, Azusa Watanabe, M.D. PhD
Published 2017Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
5
Peri-orbital lymphangioma treated by lymphatic-venous anastomosis with indocyanine green lymphography analysis by Motoi Kato, M.D, Shoji Watanabe, M.D. PhD, Takuya Iida, M.D. PhD, Azusa Watanabe, M.D. PhD, Furuya Megumi, M.D
Published 2017Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
6
Tranilast Inhibits Pulmonary Fibrosis by Suppressing TGFβ/SMAD2 Pathway by Kato M, Takahashi F, Sato T, Mitsuishi Y, Tajima K, Ihara H, Nurwidya F, Baskoro H, Murakami A, Kobayashi I, Hidayat M, Shimada N, Sasaki S, Mineki R, Fujimura T, Kumasaka T, Niwa SI, Takahashi K
Published 2020Call Number: Loading…Connect to this object online.
Located: Loading…
Book